课题基金 / 基金详情

Dissection of the Mechanism of Insulin Resistance by Transgenic and knockout Mice Technology

Dissection of the Mechanism of Insulin Resistance by Transgenic and knockout Mice Technology
通过转基因和基因敲除小鼠技术剖析胰岛素抵抗机制
批准号:
10470229
负责人:
TOBE Kazuyuki
金额:
$9.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

TOBE Kazuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
2型糖尿病是由两种生理缺陷引起的:对胰岛素作用的抵抗和胰岛素分泌缺陷。用于创建2型糖尿病动物模型的转基因和基因敲除技术对新鉴定的参与体内葡萄糖稳态调节的分子的调节产生了重大影响。(i)IRS-1和IRS-2基因敲除小鼠胰岛素抵抗和糖尿病的发生为了理解2型糖尿病发展的分子基础,我们已经产生了IRS- 1和IRS-2敲除小鼠(Tamemoto H,et al. Nature 372:182-186,1994 ; Kubota,N.,例如,Diabetes,49:1880-1889,2000)。我们证明了这两种小鼠都表现出胰岛素抵抗。然而,虽然IRS-1敲除小鼠保持正常的葡萄糖耐量,其中β细胞能够增殖(Terauchi Y,et al. J Clin Invest 99:861-866,1997),IRS-2敲除小鼠发展糖尿病,其中β细胞不能增殖。有可能β细胞的能力, 关于我们 2型糖尿病的发病机制可能与胰岛素抵抗有关。我们还证明了缺乏PI 3-激酶85 kDa亚基的小鼠显示出增加的胰岛素敏感性(Terauchi,Y.et al.,Nature Genetics 21:230-235,1999)。(ii)肥胖引起的胰岛素抵抗的机制肥胖被定义为脂肪组织的过度积累。我们研究了肥胖诱导胰岛素抵抗的分子基础。首先,我们研究了噻唑烷二酮(thiazolidinedione),一种PPAR γ激动剂,改善胰岛素抵抗的分子机制。TZD对Zucker fa/fa大鼠的给药导致胰岛素抵抗的显著改善。脂肪组织的组织学检查显示较小脂肪细胞的数量显著增加,而较大脂肪细胞的数量减少(Okuno,A.,例如,J.Clin. Invest. 101:1354-1361,1998)。我们进一步产生了PPAR γ敲除小鼠(Kubota N,et al.,Mol Cell 4:597-609,1999),并证明杂合子在高脂肪饮食下被保护免于肥胖和胰岛素抗性。杂合子胰岛素抵抗的改善,至少部分地解释了血清瘦素浓度的增加。我们还证明,在人中,较低活性的PPARg多态性(密码子12处的丙氨酸)与较高活性的PPARg多态性(密码子12处的脯氨酸)相比,被保护免于胰岛素抗性和糖尿病的发展(Hara,K.,等人:Biochem.Biophys.Res. Commun. 271:212-216,2000减
英文摘要
Type 2 diabetes is caused by two physiological defects : resistance to insulin action and defects in insulin secretion. Transgenic and knockout technology used to create animal models of type 2 diabetes have had a major impact in the regulation of newly identified molecules implicated in the regulation of glucose homeostasis in vivo.(i) Development of insulin resistance and diabetes in IRS-1 and IRS-2 knockout mice. To understand the molecular basis of type 2 diabetes development, we have generated IRS- 1 and IRS-2 knockout mice (Tamemoto H, et al. Nature 372 : 182-186, 1994 ; Kubota, N., et al., Diabetes, 49 : 1880-1889, 2000). We demonstrated that both of these mice showed insulin resistance. However, while IRS-1 knockout mice remained normal glucose tolerance in which β cells are able to proliferate (Terauchi Y, et al., J Clin Invest 99 : 861-866, 1997), IRS-2 knockout mice developed diabetes in which β cells are not able to proliferate. It is possible that the ability of β cells to … More proliferate in response to insulin resistance may determine the process for human type 2 diabetes development. We also demonstrated that mice lacking PI3-kinase 85kDa subunit showed increased insulin sensitivity (Terauchi, Y.et al., Nature Genetics 21 : 230-235, 1999).(ii) Mechanisms of obesity-induced insulin resistanceObesity is defined as an excessive accumulation of adipose tissue. We investigated the molecular basis of obesityinduced insulin resistance. First, we studied the molecular mechanism of how thiazolidinedione, a PPAR γ agonist, improves insulin resistance. Administration of TZD into Zucker fa/fa rats resulted in a marked improvement of insulin resistance. Histological examination of adipose tissue revealed a marked increase in the number of smaller adipocytes with a decreased number of larger adipocytes (Okuno, A., et al., J.Clin. Invest. 101 : 1354-1361, 1998). We further generated PPAR γ knockout mice (Kubota N, et al., Mol Cell 4 : 597-609, 1999) and demonstrated that heterozygotes were protected from obesity and insulin resistance under a high-fat diet. Amelioration of insulin resistance in heterozygotes were explained, at least in part, by increased serum leptin concentration. We also demonstrated that, in human, the lower activity PPARg polymorphism, alanine at codn 12, are protected from the development of insulin resistance and diabetes compared the higher one, proline at codon 12 (Hara, K., et al : Biochem.Biophys.Res. Commun. 271 : 212-216, 2000 Less
期刊论文(114)
专著(0)
科研奖励(0)
会议论文
Oakada, T., et al.: "Variants of neurogenis 3 gene are not asoociated with type 2 diabetes in Japanese subjects."Diabetologia. 44. 241-244 (2001)
Oakada, T., 等人:“neurogenis 3 基因的变异与日本受试者的 2 型糖尿病无关。”Diabetologia。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Okada,T., et al.: "Variants of neurogenis 3 gene are not asoociated with type 2 diabetes mellitus in the Japanese."Diabetologia. 44. 241-244 (2001)
Okada,T., et al.:“neurogenis 3 基因的变异与日本人的 2 型糖尿病无关。”Diabetologia。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamauchi, T., et al.: "Constitutive tyrosine phosphorylation of Erb B-2 via Jak2 by autocrine secretion of prolactin in human breast cancer."J.Biol.Chem.. 275. 33937-33944 (2000)
Yamauchi, T., et al.:“人乳腺癌中催乳素的自分泌通过 Jak2 对 Erb B-2 进行组成型酪氨酸磷酸化。”J.Biol.Chem.. 275. 33937-33944 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamauchi, T., et al.: "Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase(P13-kinase), and concomitantly P13-kinase activation via JAK2 kina
Yamauchi, T. 等人:“生长激素和催乳素刺激胰岛素受体底物-1、-2 和 -3 的酪氨酸磷酸化,它们与 p85 磷脂酰肌醇 3-激酶(P13-激酶)以及伴随的 P13-激酶相关
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
37
    The role of M2-like macrophages in glucose metabolism
    • 批准号:
      26461327
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2014
    • 负责人:
      TOBE Kazuyuki
    • 依托单位:
    Regulation of insulin resistance by adipose tissue M1/M2 macrophages.
    • 批准号:
      21591126
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2009
    • 负责人:
      TOBE Kazuyuki
    • 依托单位:
    Dissection of the role of IRS family proteins in the growth and development of pancreatic β cells
    • 批准号:
      17390261
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.86万
    • 财政年份:
      2005
    • 负责人:
      TOBE Kazuyuki
    • 依托单位:
    Mechanism of insulin resistance and strategy of treatment
    • 批准号:
      15390284
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.47万
    • 财政年份:
      2003
    • 负责人:
      TOBE Kazuyuki
    • 依托单位:
    海外基金